Evaluation of the costs of the introduction of the human papilloma virus vaccine in Niger

The main objective of the study is to evaluate the additional cost of integrating the HPV vaccine into Niger’s Expanded Vaccination Program (EPI), based on the costs observed during the first phase of the project. demonstration implemented in the Health Districts of Niamey III, Niamey IV and Madarounfa.

The specific objectives of the study are to estimate the total financial and economic costs of integrating HPV vaccine into the EPI program, to estimate the cost per administered dose; and to estimate the cost per Fully Vaccinated Girl (IVF)